Clinical trial
Observational Study Assessing for Effect of CREON on Symptoms of Exocrine Pancreatic Insufficiency (EPI) in Patients With EPI Due to Chronic Pancreatitis (CP)
NCT04949828 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study Assessing for Effect of CREON on Symptoms of Exocrine Pancreatic Insufficiency (EPI) in Patients With EPI Due to Chronic Pancreatitis (CP)
- Lead sponsor
- AbbVie
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 16, 2021
- Completion date
- February 29, 2024
- Enrollment
- 63 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pancreatitis